nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—osteoarthritis—Prednisone—rheumatoid arthritis	0.196	0.5	CpDpCtD
Meloxicam—osteoarthritis—Methylprednisolone—rheumatoid arthritis	0.196	0.5	CpDpCtD
Meloxicam—PTGS2—rheumatoid arthritis	0.139	1	CbGaD
Meloxicam—PGD—Methotrexate—rheumatoid arthritis	0.075	0.224	CbGbCtD
Meloxicam—PTGS2—Triamcinolone—rheumatoid arthritis	0.0303	0.0905	CbGbCtD
Meloxicam—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0303	0.0905	CbGbCtD
Meloxicam—PTGS2—Betamethasone—rheumatoid arthritis	0.026	0.0776	CbGbCtD
Meloxicam—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0256	0.0764	CbGbCtD
Meloxicam—ABCC4—Methotrexate—rheumatoid arthritis	0.0207	0.0617	CbGbCtD
Meloxicam—CYP2C9—Leflunomide—rheumatoid arthritis	0.0167	0.0498	CbGbCtD
Meloxicam—PTGS2—Dexamethasone—rheumatoid arthritis	0.0151	0.0452	CbGbCtD
Meloxicam—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.0119	0.0354	CbGbCtD
Meloxicam—CYP2C8—Cyclosporine—rheumatoid arthritis	0.0112	0.0334	CbGbCtD
Meloxicam—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0107	0.032	CbGbCtD
Meloxicam—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00791	0.0236	CbGbCtD
Meloxicam—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00781	0.0233	CbGbCtD
Meloxicam—CYP2C8—Dexamethasone—rheumatoid arthritis	0.00738	0.022	CbGbCtD
Meloxicam—CYP3A4—Triamcinolone—rheumatoid arthritis	0.006	0.0179	CbGbCtD
Meloxicam—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00515	0.0154	CbGbCtD
Meloxicam—CYP3A4—Betamethasone—rheumatoid arthritis	0.00514	0.0153	CbGbCtD
Meloxicam—CYP3A4—Prednisolone—rheumatoid arthritis	0.00508	0.0151	CbGbCtD
Meloxicam—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00481	0.0144	CbGbCtD
Meloxicam—CYP3A4—Prednisone—rheumatoid arthritis	0.00479	0.0143	CbGbCtD
Meloxicam—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00454	0.0136	CbGbCtD
Meloxicam—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00299	0.00893	CbGbCtD
Meloxicam—Lornoxicam—PTGS2—rheumatoid arthritis	0.000536	0.341	CrCbGaD
Meloxicam—Tenoxicam—PTGS2—rheumatoid arthritis	0.000478	0.304	CrCbGaD
Meloxicam—PTGS2—skeletal joint—rheumatoid arthritis	0.000457	0.159	CbGeAlD
Meloxicam—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.000347	0.121	CbGeAlD
Meloxicam—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000328	0.159	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000323	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000323	0.156	CbGdCrCtD
Meloxicam—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000315	0.153	CbGdCrCtD
Meloxicam—PTGS2—cartilage tissue—rheumatoid arthritis	0.000307	0.107	CbGeAlD
Meloxicam—Piroxicam—PTGS2—rheumatoid arthritis	0.000295	0.188	CrCbGaD
Meloxicam—Piroxicam—ALB—rheumatoid arthritis	0.000263	0.167	CrCbGaD
Meloxicam—PGD—parotid gland—rheumatoid arthritis	0.000217	0.0756	CbGeAlD
Meloxicam—PGD—saliva-secreting gland—rheumatoid arthritis	0.000208	0.0724	CbGeAlD
Meloxicam—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000198	0.0957	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000195	0.0942	CbGdCrCtD
Meloxicam—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000195	0.0942	CbGdCrCtD
Meloxicam—PGD—connective tissue—rheumatoid arthritis	0.000191	0.0665	CbGeAlD
Meloxicam—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.00019	0.0921	CbGdCrCtD
Meloxicam—PGD—lymphoid tissue—rheumatoid arthritis	0.00014	0.0486	CbGeAlD
Meloxicam—PGD—digestive system—rheumatoid arthritis	0.000138	0.048	CbGeAlD
Meloxicam—PGD—tendon—rheumatoid arthritis	0.000131	0.0457	CbGeAlD
Meloxicam—ABCC4—digestive system—rheumatoid arthritis	9.81e-05	0.0342	CbGeAlD
Meloxicam—ABCC4—tendon—rheumatoid arthritis	9.34e-05	0.0325	CbGeAlD
Meloxicam—PTGS1—connective tissue—rheumatoid arthritis	8e-05	0.0278	CbGeAlD
Meloxicam—PTGS2—connective tissue—rheumatoid arthritis	7.64e-05	0.0266	CbGeAlD
Meloxicam—CYP2C9—digestive system—rheumatoid arthritis	6.33e-05	0.022	CbGeAlD
Meloxicam—PTGS1—digestive system—rheumatoid arthritis	5.78e-05	0.0201	CbGeAlD
Meloxicam—PTGS2—lymphoid tissue—rheumatoid arthritis	5.59e-05	0.0195	CbGeAlD
Meloxicam—PTGS2—digestive system—rheumatoid arthritis	5.52e-05	0.0192	CbGeAlD
Meloxicam—PTGS1—tendon—rheumatoid arthritis	5.5e-05	0.0191	CbGeAlD
Meloxicam—Haemoglobin—Methotrexate—rheumatoid arthritis	5.41e-05	0.000521	CcSEcCtD
Meloxicam—Hypotension—Methylprednisolone—rheumatoid arthritis	5.4e-05	0.00052	CcSEcCtD
Meloxicam—Pain—Prednisolone—rheumatoid arthritis	5.38e-05	0.000519	CcSEcCtD
Meloxicam—Hepatitis—Methotrexate—rheumatoid arthritis	5.38e-05	0.000518	CcSEcCtD
Meloxicam—Haemorrhage—Methotrexate—rheumatoid arthritis	5.38e-05	0.000518	CcSEcCtD
Meloxicam—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5.34e-05	0.000515	CcSEcCtD
Meloxicam—Pharyngitis—Methotrexate—rheumatoid arthritis	5.34e-05	0.000514	CcSEcCtD
Meloxicam—Nausea—Leflunomide—rheumatoid arthritis	5.32e-05	0.000513	CcSEcCtD
Meloxicam—Urinary tract disorder—Methotrexate—rheumatoid arthritis	5.31e-05	0.000512	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	5.31e-05	0.000511	CcSEcCtD
Meloxicam—Fatigue—Hydrocortisone—rheumatoid arthritis	5.3e-05	0.000511	CcSEcCtD
Meloxicam—Vision blurred—Prednisone—rheumatoid arthritis	5.28e-05	0.000509	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—rheumatoid arthritis	5.27e-05	0.000508	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	5.27e-05	0.000508	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	5.26e-05	0.000507	CcSEcCtD
Meloxicam—Pain—Hydrocortisone—rheumatoid arthritis	5.26e-05	0.000506	CcSEcCtD
Meloxicam—PTGS2—tendon—rheumatoid arthritis	5.25e-05	0.0183	CbGeAlD
Meloxicam—Oedema—Dexamethasone—rheumatoid arthritis	5.25e-05	0.000506	CcSEcCtD
Meloxicam—Anaphylactic shock—Betamethasone—rheumatoid arthritis	5.25e-05	0.000506	CcSEcCtD
Meloxicam—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	5.25e-05	0.000506	CcSEcCtD
Meloxicam—Oedema—Betamethasone—rheumatoid arthritis	5.25e-05	0.000506	CcSEcCtD
Meloxicam—Insomnia—Triamcinolone—rheumatoid arthritis	5.23e-05	0.000504	CcSEcCtD
Meloxicam—Insomnia—Methylprednisolone—rheumatoid arthritis	5.22e-05	0.000503	CcSEcCtD
Meloxicam—Infection—Betamethasone—rheumatoid arthritis	5.22e-05	0.000503	CcSEcCtD
Meloxicam—Infection—Dexamethasone—rheumatoid arthritis	5.22e-05	0.000503	CcSEcCtD
Meloxicam—Ill-defined disorder—Prednisone—rheumatoid arthritis	5.2e-05	0.000501	CcSEcCtD
Meloxicam—Paraesthesia—Triamcinolone—rheumatoid arthritis	5.2e-05	0.000501	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisolone—rheumatoid arthritis	5.19e-05	0.0005	CcSEcCtD
Meloxicam—Paraesthesia—Methylprednisolone—rheumatoid arthritis	5.19e-05	0.0005	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—rheumatoid arthritis	5.18e-05	0.0005	CcSEcCtD
Meloxicam—Anaemia—Prednisone—rheumatoid arthritis	5.18e-05	0.000499	CcSEcCtD
Meloxicam—Shock—Betamethasone—rheumatoid arthritis	5.17e-05	0.000498	CcSEcCtD
Meloxicam—Shock—Dexamethasone—rheumatoid arthritis	5.17e-05	0.000498	CcSEcCtD
Meloxicam—Dyspnoea—Triamcinolone—rheumatoid arthritis	5.16e-05	0.000497	CcSEcCtD
Meloxicam—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.15e-05	0.000496	CcSEcCtD
Meloxicam—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.15e-05	0.000496	CcSEcCtD
Meloxicam—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.14e-05	0.000495	CcSEcCtD
Meloxicam—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.14e-05	0.000495	CcSEcCtD
Meloxicam—Tachycardia—Dexamethasone—rheumatoid arthritis	5.13e-05	0.000494	CcSEcCtD
Meloxicam—Tachycardia—Betamethasone—rheumatoid arthritis	5.13e-05	0.000494	CcSEcCtD
Meloxicam—Angioedema—Prednisone—rheumatoid arthritis	5.12e-05	0.000493	CcSEcCtD
Meloxicam—Hypersensitivity—Cyclosporine—rheumatoid arthritis	5.1e-05	0.000491	CcSEcCtD
Meloxicam—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.09e-05	0.000491	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—rheumatoid arthritis	5.09e-05	0.00049	CcSEcCtD
Meloxicam—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.08e-05	0.00049	CcSEcCtD
Meloxicam—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	5.08e-05	0.000489	CcSEcCtD
Meloxicam—Hyperhidrosis—Betamethasone—rheumatoid arthritis	5.08e-05	0.000489	CcSEcCtD
Meloxicam—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	5.07e-05	0.000488	CcSEcCtD
Meloxicam—Malaise—Prednisone—rheumatoid arthritis	5.05e-05	0.000487	CcSEcCtD
Meloxicam—Vertigo—Prednisone—rheumatoid arthritis	5.03e-05	0.000485	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—rheumatoid arthritis	5.03e-05	0.000484	CcSEcCtD
Meloxicam—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.03e-05	0.000484	CcSEcCtD
Meloxicam—Syncope—Prednisone—rheumatoid arthritis	5.03e-05	0.000484	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—rheumatoid arthritis	5.02e-05	0.000483	CcSEcCtD
Meloxicam—Urticaria—Prednisolone—rheumatoid arthritis	5e-05	0.000482	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—rheumatoid arthritis	4.99e-05	0.000481	CcSEcCtD
Meloxicam—Fatigue—Triamcinolone—rheumatoid arthritis	4.99e-05	0.000481	CcSEcCtD
Meloxicam—Fatigue—Methylprednisolone—rheumatoid arthritis	4.98e-05	0.00048	CcSEcCtD
Meloxicam—Asthenia—Cyclosporine—rheumatoid arthritis	4.96e-05	0.000478	CcSEcCtD
Meloxicam—Pain—Triamcinolone—rheumatoid arthritis	4.95e-05	0.000477	CcSEcCtD
Meloxicam—Loss of consciousness—Prednisone—rheumatoid arthritis	4.93e-05	0.000475	CcSEcCtD
Meloxicam—Hypotension—Dexamethasone—rheumatoid arthritis	4.91e-05	0.000473	CcSEcCtD
Meloxicam—Hypotension—Betamethasone—rheumatoid arthritis	4.91e-05	0.000473	CcSEcCtD
Meloxicam—Pruritus—Cyclosporine—rheumatoid arthritis	4.89e-05	0.000471	CcSEcCtD
Meloxicam—Urticaria—Hydrocortisone—rheumatoid arthritis	4.88e-05	0.00047	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—rheumatoid arthritis	4.88e-05	0.00047	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—rheumatoid arthritis	4.86e-05	0.000468	CcSEcCtD
Meloxicam—Abdominal pain—Hydrocortisone—rheumatoid arthritis	4.86e-05	0.000468	CcSEcCtD
Meloxicam—Body temperature increased—Hydrocortisone—rheumatoid arthritis	4.86e-05	0.000468	CcSEcCtD
Meloxicam—Convulsion—Prednisone—rheumatoid arthritis	4.86e-05	0.000468	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—rheumatoid arthritis	4.85e-05	0.000467	CcSEcCtD
Meloxicam—Hypertension—Prednisone—rheumatoid arthritis	4.84e-05	0.000466	CcSEcCtD
Meloxicam—CYP3A4—digestive system—rheumatoid arthritis	4.82e-05	0.0168	CbGeAlD
Meloxicam—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	4.78e-05	0.000461	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	4.78e-05	0.000461	CcSEcCtD
Meloxicam—Arthralgia—Prednisone—rheumatoid arthritis	4.77e-05	0.00046	CcSEcCtD
Meloxicam—Myalgia—Prednisone—rheumatoid arthritis	4.77e-05	0.00046	CcSEcCtD
Meloxicam—Feeling abnormal—Triamcinolone—rheumatoid arthritis	4.77e-05	0.00046	CcSEcCtD
Meloxicam—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	4.76e-05	0.000458	CcSEcCtD
Meloxicam—Anxiety—Prednisone—rheumatoid arthritis	4.75e-05	0.000458	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—rheumatoid arthritis	4.75e-05	0.000458	CcSEcCtD
Meloxicam—Insomnia—Betamethasone—rheumatoid arthritis	4.75e-05	0.000458	CcSEcCtD
Meloxicam—Insomnia—Dexamethasone—rheumatoid arthritis	4.75e-05	0.000458	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	4.74e-05	0.000456	CcSEcCtD
Meloxicam—Diarrhoea—Cyclosporine—rheumatoid arthritis	4.73e-05	0.000456	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	4.72e-05	0.000455	CcSEcCtD
Meloxicam—Paraesthesia—Betamethasone—rheumatoid arthritis	4.72e-05	0.000454	CcSEcCtD
Meloxicam—Paraesthesia—Dexamethasone—rheumatoid arthritis	4.72e-05	0.000454	CcSEcCtD
Meloxicam—Discomfort—Prednisone—rheumatoid arthritis	4.71e-05	0.000454	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—rheumatoid arthritis	4.71e-05	0.000454	CcSEcCtD
Meloxicam—Erythema—Methotrexate—rheumatoid arthritis	4.68e-05	0.000451	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—rheumatoid arthritis	4.68e-05	0.000451	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisolone—rheumatoid arthritis	4.64e-05	0.000447	CcSEcCtD
Meloxicam—Dyspepsia—Dexamethasone—rheumatoid arthritis	4.62e-05	0.000445	CcSEcCtD
Meloxicam—Dyspepsia—Betamethasone—rheumatoid arthritis	4.62e-05	0.000445	CcSEcCtD
Meloxicam—Urticaria—Triamcinolone—rheumatoid arthritis	4.6e-05	0.000443	CcSEcCtD
Meloxicam—Urticaria—Methylprednisolone—rheumatoid arthritis	4.59e-05	0.000442	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—rheumatoid arthritis	4.59e-05	0.000442	CcSEcCtD
Meloxicam—Body temperature increased—Triamcinolone—rheumatoid arthritis	4.58e-05	0.000441	CcSEcCtD
Meloxicam—Dizziness—Cyclosporine—rheumatoid arthritis	4.57e-05	0.000441	CcSEcCtD
Meloxicam—Anaphylactic shock—Prednisone—rheumatoid arthritis	4.57e-05	0.000441	CcSEcCtD
Meloxicam—Oedema—Prednisone—rheumatoid arthritis	4.57e-05	0.000441	CcSEcCtD
Meloxicam—Abdominal pain—Methylprednisolone—rheumatoid arthritis	4.57e-05	0.00044	CcSEcCtD
Meloxicam—Decreased appetite—Betamethasone—rheumatoid arthritis	4.57e-05	0.00044	CcSEcCtD
Meloxicam—Decreased appetite—Dexamethasone—rheumatoid arthritis	4.57e-05	0.00044	CcSEcCtD
Meloxicam—Infection—Prednisone—rheumatoid arthritis	4.54e-05	0.000438	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	4.53e-05	0.000437	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	4.53e-05	0.000437	CcSEcCtD
Meloxicam—Back pain—Methotrexate—rheumatoid arthritis	4.53e-05	0.000436	CcSEcCtD
Meloxicam—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	4.53e-05	0.000436	CcSEcCtD
Meloxicam—Fatigue—Betamethasone—rheumatoid arthritis	4.53e-05	0.000436	CcSEcCtD
Meloxicam—Fatigue—Dexamethasone—rheumatoid arthritis	4.53e-05	0.000436	CcSEcCtD
Meloxicam—Shock—Prednisone—rheumatoid arthritis	4.5e-05	0.000434	CcSEcCtD
Meloxicam—Pain—Betamethasone—rheumatoid arthritis	4.49e-05	0.000433	CcSEcCtD
Meloxicam—Pain—Dexamethasone—rheumatoid arthritis	4.49e-05	0.000433	CcSEcCtD
Meloxicam—Nervous system disorder—Prednisone—rheumatoid arthritis	4.48e-05	0.000432	CcSEcCtD
Meloxicam—Tachycardia—Prednisone—rheumatoid arthritis	4.46e-05	0.00043	CcSEcCtD
Meloxicam—Skin disorder—Prednisone—rheumatoid arthritis	4.44e-05	0.000428	CcSEcCtD
Meloxicam—Hyperhidrosis—Prednisone—rheumatoid arthritis	4.42e-05	0.000426	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—rheumatoid arthritis	4.41e-05	0.000425	CcSEcCtD
Meloxicam—Asthenia—Hydrocortisone—rheumatoid arthritis	4.41e-05	0.000425	CcSEcCtD
Meloxicam—Vomiting—Cyclosporine—rheumatoid arthritis	4.4e-05	0.000424	CcSEcCtD
Meloxicam—Rash—Cyclosporine—rheumatoid arthritis	4.36e-05	0.00042	CcSEcCtD
Meloxicam—Dermatitis—Cyclosporine—rheumatoid arthritis	4.36e-05	0.00042	CcSEcCtD
Meloxicam—Pruritus—Hydrocortisone—rheumatoid arthritis	4.35e-05	0.000419	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—rheumatoid arthritis	4.35e-05	0.000419	CcSEcCtD
Meloxicam—Headache—Cyclosporine—rheumatoid arthritis	4.33e-05	0.000417	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—rheumatoid arthritis	4.33e-05	0.000417	CcSEcCtD
Meloxicam—Feeling abnormal—Dexamethasone—rheumatoid arthritis	4.33e-05	0.000417	CcSEcCtD
Meloxicam—Feeling abnormal—Betamethasone—rheumatoid arthritis	4.33e-05	0.000417	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.29e-05	0.000414	CcSEcCtD
Meloxicam—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.29e-05	0.000414	CcSEcCtD
Meloxicam—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.26e-05	0.000411	CcSEcCtD
Meloxicam—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.25e-05	0.00041	CcSEcCtD
Meloxicam—Malaise—Methotrexate—rheumatoid arthritis	4.22e-05	0.000407	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—rheumatoid arthritis	4.21e-05	0.000405	CcSEcCtD
Meloxicam—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.21e-05	0.000405	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—rheumatoid arthritis	4.19e-05	0.000404	CcSEcCtD
Meloxicam—Urticaria—Dexamethasone—rheumatoid arthritis	4.17e-05	0.000402	CcSEcCtD
Meloxicam—Urticaria—Betamethasone—rheumatoid arthritis	4.17e-05	0.000402	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.17e-05	0.000401	CcSEcCtD
Meloxicam—Dizziness—Prednisolone—rheumatoid arthritis	4.16e-05	0.000401	CcSEcCtD
Meloxicam—Asthenia—Triamcinolone—rheumatoid arthritis	4.15e-05	0.0004	CcSEcCtD
Meloxicam—Body temperature increased—Betamethasone—rheumatoid arthritis	4.15e-05	0.0004	CcSEcCtD
Meloxicam—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.15e-05	0.0004	CcSEcCtD
Meloxicam—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.15e-05	0.0004	CcSEcCtD
Meloxicam—Abdominal pain—Betamethasone—rheumatoid arthritis	4.15e-05	0.0004	CcSEcCtD
Meloxicam—Asthenia—Methylprednisolone—rheumatoid arthritis	4.14e-05	0.000399	CcSEcCtD
Meloxicam—Insomnia—Prednisone—rheumatoid arthritis	4.14e-05	0.000399	CcSEcCtD
Meloxicam—Nausea—Cyclosporine—rheumatoid arthritis	4.11e-05	0.000396	CcSEcCtD
Meloxicam—Paraesthesia—Prednisone—rheumatoid arthritis	4.11e-05	0.000396	CcSEcCtD
Meloxicam—Pruritus—Triamcinolone—rheumatoid arthritis	4.09e-05	0.000395	CcSEcCtD
Meloxicam—Cough—Methotrexate—rheumatoid arthritis	4.09e-05	0.000394	CcSEcCtD
Meloxicam—Pruritus—Methylprednisolone—rheumatoid arthritis	4.09e-05	0.000394	CcSEcCtD
Meloxicam—Dizziness—Hydrocortisone—rheumatoid arthritis	4.06e-05	0.000392	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—rheumatoid arthritis	4.06e-05	0.000391	CcSEcCtD
Meloxicam—Dyspepsia—Prednisone—rheumatoid arthritis	4.03e-05	0.000388	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—rheumatoid arthritis	3.99e-05	0.000384	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—rheumatoid arthritis	3.99e-05	0.000384	CcSEcCtD
Meloxicam—Decreased appetite—Prednisone—rheumatoid arthritis	3.98e-05	0.000383	CcSEcCtD
Meloxicam—Rash—Prednisolone—rheumatoid arthritis	3.97e-05	0.000382	CcSEcCtD
Meloxicam—Dermatitis—Prednisolone—rheumatoid arthritis	3.96e-05	0.000382	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.96e-05	0.000381	CcSEcCtD
Meloxicam—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.95e-05	0.000381	CcSEcCtD
Meloxicam—Fatigue—Prednisone—rheumatoid arthritis	3.94e-05	0.00038	CcSEcCtD
Meloxicam—Headache—Prednisolone—rheumatoid arthritis	3.94e-05	0.00038	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—rheumatoid arthritis	3.94e-05	0.00038	CcSEcCtD
Meloxicam—Constipation—Prednisone—rheumatoid arthritis	3.91e-05	0.000377	CcSEcCtD
Meloxicam—Vomiting—Hydrocortisone—rheumatoid arthritis	3.91e-05	0.000377	CcSEcCtD
Meloxicam—Rash—Hydrocortisone—rheumatoid arthritis	3.88e-05	0.000373	CcSEcCtD
Meloxicam—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.87e-05	0.000373	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—rheumatoid arthritis	3.85e-05	0.000371	CcSEcCtD
Meloxicam—Headache—Hydrocortisone—rheumatoid arthritis	3.85e-05	0.000371	CcSEcCtD
Meloxicam—Dizziness—Triamcinolone—rheumatoid arthritis	3.83e-05	0.000369	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—rheumatoid arthritis	3.82e-05	0.000368	CcSEcCtD
Meloxicam—Dizziness—Methylprednisolone—rheumatoid arthritis	3.82e-05	0.000368	CcSEcCtD
Meloxicam—Infection—Methotrexate—rheumatoid arthritis	3.8e-05	0.000366	CcSEcCtD
Meloxicam—Feeling abnormal—Prednisone—rheumatoid arthritis	3.77e-05	0.000363	CcSEcCtD
Meloxicam—Asthenia—Dexamethasone—rheumatoid arthritis	3.77e-05	0.000363	CcSEcCtD
Meloxicam—Asthenia—Betamethasone—rheumatoid arthritis	3.77e-05	0.000363	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.75e-05	0.000361	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—rheumatoid arthritis	3.74e-05	0.000361	CcSEcCtD
Meloxicam—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3.74e-05	0.00036	CcSEcCtD
Meloxicam—Nausea—Prednisolone—rheumatoid arthritis	3.74e-05	0.00036	CcSEcCtD
Meloxicam—Pruritus—Betamethasone—rheumatoid arthritis	3.72e-05	0.000358	CcSEcCtD
Meloxicam—Pruritus—Dexamethasone—rheumatoid arthritis	3.72e-05	0.000358	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—rheumatoid arthritis	3.71e-05	0.000358	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—rheumatoid arthritis	3.69e-05	0.000356	CcSEcCtD
Meloxicam—Vomiting—Triamcinolone—rheumatoid arthritis	3.68e-05	0.000355	CcSEcCtD
Meloxicam—Vomiting—Methylprednisolone—rheumatoid arthritis	3.67e-05	0.000354	CcSEcCtD
Meloxicam—Nausea—Hydrocortisone—rheumatoid arthritis	3.65e-05	0.000352	CcSEcCtD
Meloxicam—Rash—Triamcinolone—rheumatoid arthritis	3.65e-05	0.000352	CcSEcCtD
Meloxicam—Dermatitis—Triamcinolone—rheumatoid arthritis	3.65e-05	0.000351	CcSEcCtD
Meloxicam—Rash—Methylprednisolone—rheumatoid arthritis	3.64e-05	0.000351	CcSEcCtD
Meloxicam—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.64e-05	0.00035	CcSEcCtD
Meloxicam—Urticaria—Prednisone—rheumatoid arthritis	3.63e-05	0.00035	CcSEcCtD
Meloxicam—Headache—Triamcinolone—rheumatoid arthritis	3.63e-05	0.000349	CcSEcCtD
Meloxicam—Headache—Methylprednisolone—rheumatoid arthritis	3.62e-05	0.000349	CcSEcCtD
Meloxicam—Body temperature increased—Prednisone—rheumatoid arthritis	3.62e-05	0.000348	CcSEcCtD
Meloxicam—Abdominal pain—Prednisone—rheumatoid arthritis	3.62e-05	0.000348	CcSEcCtD
Meloxicam—Diarrhoea—Betamethasone—rheumatoid arthritis	3.59e-05	0.000346	CcSEcCtD
Meloxicam—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.59e-05	0.000346	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—rheumatoid arthritis	3.57e-05	0.000344	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.48e-05	0.000335	CcSEcCtD
Meloxicam—Dizziness—Dexamethasone—rheumatoid arthritis	3.47e-05	0.000335	CcSEcCtD
Meloxicam—Dizziness—Betamethasone—rheumatoid arthritis	3.47e-05	0.000335	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—rheumatoid arthritis	3.46e-05	0.000333	CcSEcCtD
Meloxicam—Nausea—Triamcinolone—rheumatoid arthritis	3.44e-05	0.000331	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—rheumatoid arthritis	3.43e-05	0.000331	CcSEcCtD
Meloxicam—Nausea—Methylprednisolone—rheumatoid arthritis	3.43e-05	0.00033	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—rheumatoid arthritis	3.41e-05	0.000328	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—rheumatoid arthritis	3.4e-05	0.000327	CcSEcCtD
Meloxicam—Hypersensitivity—Prednisone—rheumatoid arthritis	3.37e-05	0.000325	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—rheumatoid arthritis	3.36e-05	0.000324	CcSEcCtD
Meloxicam—Vomiting—Betamethasone—rheumatoid arthritis	3.34e-05	0.000322	CcSEcCtD
Meloxicam—Vomiting—Dexamethasone—rheumatoid arthritis	3.34e-05	0.000322	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—rheumatoid arthritis	3.32e-05	0.00032	CcSEcCtD
Meloxicam—Rash—Dexamethasone—rheumatoid arthritis	3.31e-05	0.000319	CcSEcCtD
Meloxicam—Rash—Betamethasone—rheumatoid arthritis	3.31e-05	0.000319	CcSEcCtD
Meloxicam—Dermatitis—Dexamethasone—rheumatoid arthritis	3.31e-05	0.000319	CcSEcCtD
Meloxicam—Dermatitis—Betamethasone—rheumatoid arthritis	3.31e-05	0.000319	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.3e-05	0.000318	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—rheumatoid arthritis	3.3e-05	0.000317	CcSEcCtD
Meloxicam—Headache—Dexamethasone—rheumatoid arthritis	3.29e-05	0.000317	CcSEcCtD
Meloxicam—Headache—Betamethasone—rheumatoid arthritis	3.29e-05	0.000317	CcSEcCtD
Meloxicam—Asthenia—Prednisone—rheumatoid arthritis	3.28e-05	0.000316	CcSEcCtD
Meloxicam—Pain—Methotrexate—rheumatoid arthritis	3.27e-05	0.000315	CcSEcCtD
Meloxicam—Pruritus—Prednisone—rheumatoid arthritis	3.24e-05	0.000312	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	3.16e-05	0.00137	CbGpPWpGaD
Meloxicam—Feeling abnormal—Methotrexate—rheumatoid arthritis	3.15e-05	0.000303	CcSEcCtD
Meloxicam—Diarrhoea—Prednisone—rheumatoid arthritis	3.13e-05	0.000301	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.13e-05	0.000301	CcSEcCtD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	3.12e-05	0.00136	CbGpPWpGaD
Meloxicam—Nausea—Betamethasone—rheumatoid arthritis	3.12e-05	0.000301	CcSEcCtD
Meloxicam—Nausea—Dexamethasone—rheumatoid arthritis	3.12e-05	0.000301	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—rheumatoid arthritis	3.04e-05	0.000293	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	3.04e-05	0.00132	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.03e-05	0.00131	CbGpPWpGaD
Meloxicam—Dizziness—Prednisone—rheumatoid arthritis	3.02e-05	0.000291	CcSEcCtD
Meloxicam—PGD—Metabolism—ENO1—rheumatoid arthritis	3.02e-05	0.00131	CbGpPWpGaD
Meloxicam—Body temperature increased—Methotrexate—rheumatoid arthritis	3.02e-05	0.000291	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—rheumatoid arthritis	3.02e-05	0.000291	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	3.02e-05	0.00131	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	2.97e-05	0.00129	CbGpPWpGaD
Meloxicam—PGD—Disease—PRKCQ—rheumatoid arthritis	2.95e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	2.95e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	2.95e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	2.95e-05	0.00128	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	2.92e-05	0.00127	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	2.91e-05	0.00126	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—GATA3—rheumatoid arthritis	2.91e-05	0.00126	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	2.91e-05	0.00126	CbGpPWpGaD
Meloxicam—Vomiting—Prednisone—rheumatoid arthritis	2.91e-05	0.00028	CcSEcCtD
Meloxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	2.91e-05	0.00126	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT1—rheumatoid arthritis	2.9e-05	0.00126	CbGpPWpGaD
Meloxicam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	2.9e-05	0.00126	CbGpPWpGaD
Meloxicam—Rash—Prednisone—rheumatoid arthritis	2.88e-05	0.000278	CcSEcCtD
Meloxicam—Dermatitis—Prednisone—rheumatoid arthritis	2.88e-05	0.000278	CcSEcCtD
Meloxicam—Headache—Prednisone—rheumatoid arthritis	2.87e-05	0.000276	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	2.82e-05	0.00122	CbGpPWpGaD
Meloxicam—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.82e-05	0.000271	CcSEcCtD
Meloxicam—PTGS1—Metabolism—FADS2—rheumatoid arthritis	2.81e-05	0.00122	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	2.79e-05	0.00121	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	2.77e-05	0.0012	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TIMP1—rheumatoid arthritis	2.76e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	2.74e-05	0.00119	CbGpPWpGaD
Meloxicam—Asthenia—Methotrexate—rheumatoid arthritis	2.74e-05	0.000264	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	2.73e-05	0.00119	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	2.72e-05	0.00118	CbGpPWpGaD
Meloxicam—Nausea—Prednisone—rheumatoid arthritis	2.72e-05	0.000262	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—rheumatoid arthritis	2.7e-05	0.000261	CcSEcCtD
Meloxicam—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	2.69e-05	0.00117	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	2.69e-05	0.00117	CbGpPWpGaD
Meloxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	2.68e-05	0.00116	CbGpPWpGaD
Meloxicam—Diarrhoea—Methotrexate—rheumatoid arthritis	2.62e-05	0.000252	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—rheumatoid arthritis	2.53e-05	0.000244	CcSEcCtD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—ALB—rheumatoid arthritis	2.52e-05	0.00109	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	2.5e-05	0.00108	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—RASGRP1—rheumatoid arthritis	2.48e-05	0.00108	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—SYK—rheumatoid arthritis	2.47e-05	0.00107	CbGpPWpGaD
Meloxicam—Vomiting—Methotrexate—rheumatoid arthritis	2.43e-05	0.000234	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—PRKCQ—rheumatoid arthritis	2.43e-05	0.00105	CbGpPWpGaD
Meloxicam—Rash—Methotrexate—rheumatoid arthritis	2.41e-05	0.000232	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—rheumatoid arthritis	2.41e-05	0.000232	CcSEcCtD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	2.41e-05	0.00104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	2.4e-05	0.00104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	2.4e-05	0.00104	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	2.4e-05	0.00104	CbGpPWpGaD
Meloxicam—Headache—Methotrexate—rheumatoid arthritis	2.39e-05	0.000231	CcSEcCtD
Meloxicam—PTGS1—Biological oxidations—POMC—rheumatoid arthritis	2.38e-05	0.00103	CbGpPWpGaD
Meloxicam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	2.36e-05	0.00102	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.33e-05	0.00101	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	2.29e-05	0.000992	CbGpPWpGaD
Meloxicam—Nausea—Methotrexate—rheumatoid arthritis	2.27e-05	0.000219	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	2.24e-05	0.00097	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	2.23e-05	0.000968	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—FADS2—rheumatoid arthritis	2.23e-05	0.000967	CbGpPWpGaD
Meloxicam—ABCC4—NRF2 pathway—TGFB1—rheumatoid arthritis	2.22e-05	0.000964	CbGpPWpGaD
Meloxicam—PGD—Disease—CCR5—rheumatoid arthritis	2.22e-05	0.000962	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	2.21e-05	0.00096	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	2.2e-05	0.000956	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.19e-05	0.00095	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CAT—rheumatoid arthritis	2.17e-05	0.000943	CbGpPWpGaD
Meloxicam—PGD—Disease—MTHFR—rheumatoid arthritis	2.17e-05	0.00094	CbGpPWpGaD
Meloxicam—PGD—Disease—HLA-A—rheumatoid arthritis	2.16e-05	0.000937	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	2.13e-05	0.000922	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PTK2—rheumatoid arthritis	2.06e-05	0.000895	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	2.04e-05	0.000887	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CSF2—rheumatoid arthritis	1.99e-05	0.000865	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	1.98e-05	0.000857	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.96e-05	0.000849	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.95e-05	0.000848	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.95e-05	0.000848	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SYVN1—rheumatoid arthritis	1.93e-05	0.000835	CbGpPWpGaD
Meloxicam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.92e-05	0.000831	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	1.9e-05	0.000822	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6ST—rheumatoid arthritis	1.9e-05	0.000822	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	1.89e-05	0.000819	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS2—rheumatoid arthritis	1.88e-05	0.000815	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PLD4—rheumatoid arthritis	1.87e-05	0.000813	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.85e-05	0.000804	CbGpPWpGaD
Meloxicam—PGD—Disease—CD80—rheumatoid arthritis	1.82e-05	0.000791	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.82e-05	0.000788	CbGpPWpGaD
Meloxicam—PGD—Metabolism—MTHFR—rheumatoid arthritis	1.82e-05	0.000787	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—FADS2—rheumatoid arthritis	1.81e-05	0.000787	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ACAN—rheumatoid arthritis	1.81e-05	0.000785	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2RA—rheumatoid arthritis	1.8e-05	0.00078	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	1.79e-05	0.000775	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—rheumatoid arthritis	1.77e-05	0.000767	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	1.74e-05	0.000755	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	1.74e-05	0.000754	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ACAN—rheumatoid arthritis	1.72e-05	0.000744	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—MMP1—rheumatoid arthritis	1.71e-05	0.000744	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC25A12—rheumatoid arthritis	1.7e-05	0.000738	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6R—rheumatoid arthritis	1.69e-05	0.000733	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGES—rheumatoid arthritis	1.66e-05	0.000718	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GC—rheumatoid arthritis	1.66e-05	0.000718	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC25A12—rheumatoid arthritis	1.61e-05	0.0007	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	1.59e-05	0.000692	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.59e-05	0.000691	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—FN1—rheumatoid arthritis	1.56e-05	0.000679	CbGpPWpGaD
Meloxicam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.55e-05	0.000674	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS2—rheumatoid arthritis	1.55e-05	0.000671	CbGpPWpGaD
Meloxicam—PGD—Disease—TYK2—rheumatoid arthritis	1.54e-05	0.000668	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PLB1—rheumatoid arthritis	1.54e-05	0.000668	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—POMC—rheumatoid arthritis	1.54e-05	0.000667	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS3—rheumatoid arthritis	1.51e-05	0.000656	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.51e-05	0.000654	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLD4—rheumatoid arthritis	1.49e-05	0.000645	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	1.48e-05	0.00064	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	1.47e-05	0.000639	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PLB1—rheumatoid arthritis	1.46e-05	0.000633	CbGpPWpGaD
Meloxicam—PGD—Metabolism—POMC—rheumatoid arthritis	1.45e-05	0.00063	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ACAN—rheumatoid arthritis	1.44e-05	0.000623	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	1.4e-05	0.000609	CbGpPWpGaD
Meloxicam—PGD—Disease—CD4—rheumatoid arthritis	1.39e-05	0.000604	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—rheumatoid arthritis	1.38e-05	0.0006	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	1.38e-05	0.000597	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	1.35e-05	0.000586	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MED1—rheumatoid arthritis	1.35e-05	0.000585	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RBPJ—rheumatoid arthritis	1.35e-05	0.000584	CbGpPWpGaD
Meloxicam—PGD—Metabolism—ALB—rheumatoid arthritis	1.32e-05	0.000574	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GC—rheumatoid arthritis	1.31e-05	0.00057	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGES—rheumatoid arthritis	1.31e-05	0.00057	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—ALB—rheumatoid arthritis	1.3e-05	0.000564	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NOS3—rheumatoid arthritis	1.27e-05	0.000549	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	1.25e-05	0.000544	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ACP5—rheumatoid arthritis	1.25e-05	0.000544	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	1.25e-05	0.000543	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS3—rheumatoid arthritis	1.24e-05	0.000539	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.23e-05	0.000532	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLB1—rheumatoid arthritis	1.22e-05	0.00053	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	1.21e-05	0.000526	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLD4—rheumatoid arthritis	1.21e-05	0.000525	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.2e-05	0.000522	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ACP5—rheumatoid arthritis	1.19e-05	0.000516	CbGpPWpGaD
Meloxicam—PTGS2—Disease—B3GNT2—rheumatoid arthritis	1.19e-05	0.000516	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.18e-05	0.000513	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ACAN—rheumatoid arthritis	1.17e-05	0.000507	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—rheumatoid arthritis	1.16e-05	0.000502	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—BGN—rheumatoid arthritis	1.13e-05	0.00049	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.12e-05	0.000488	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	1.11e-05	0.000482	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC25A12—rheumatoid arthritis	1.1e-05	0.000477	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.09e-05	0.000474	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MED1—rheumatoid arthritis	1.07e-05	0.000465	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BGN—rheumatoid arthritis	1.07e-05	0.000464	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TLE3—rheumatoid arthritis	1.07e-05	0.000464	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGES—rheumatoid arthritis	1.07e-05	0.000464	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GC—rheumatoid arthritis	1.07e-05	0.000464	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—rheumatoid arthritis	1.05e-05	0.000457	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	1.04e-05	0.000451	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1e-05	0.000435	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—rheumatoid arthritis	1e-05	0.000434	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	9.96e-06	0.000432	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ACP5—rheumatoid arthritis	9.96e-06	0.000432	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLB1—rheumatoid arthritis	9.94e-06	0.000431	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	9.85e-06	0.000427	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SLC11A1—rheumatoid arthritis	9.77e-06	0.000424	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	9.74e-06	0.000422	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NFATC1—rheumatoid arthritis	9.7e-06	0.00042	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	9.52e-06	0.000413	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	9.36e-06	0.000406	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.14e-06	0.000397	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NCF2—rheumatoid arthritis	9.01e-06	0.000391	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—BGN—rheumatoid arthritis	8.97e-06	0.000389	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—rheumatoid arthritis	8.96e-06	0.000388	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	8.95e-06	0.000388	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MED1—rheumatoid arthritis	8.72e-06	0.000378	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GC—rheumatoid arthritis	8.7e-06	0.000377	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	8.7e-06	0.000377	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ENO1—rheumatoid arthritis	8.47e-06	0.000368	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.34e-06	0.000362	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SAA1—rheumatoid arthritis	8.29e-06	0.000359	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	8.25e-06	0.000358	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	8.25e-06	0.000358	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	8.25e-06	0.000358	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—rheumatoid arthritis	8.22e-06	0.000356	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NCF1—rheumatoid arthritis	8.12e-06	0.000352	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—B3GNT2—rheumatoid arthritis	8.1e-06	0.000351	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ACP5—rheumatoid arthritis	8.1e-06	0.000351	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	8.09e-06	0.000351	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ENO1—rheumatoid arthritis	8.03e-06	0.000348	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD28—rheumatoid arthritis	7.8e-06	0.000338	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—rheumatoid arthritis	7.53e-06	0.000327	CbGpPWpGaD
Meloxicam—PTGS2—Disease—UBE2D1—rheumatoid arthritis	7.35e-06	0.000319	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BGN—rheumatoid arthritis	7.3e-06	0.000316	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.29e-06	0.000316	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	7.26e-06	0.000315	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADRBK1—rheumatoid arthritis	7.12e-06	0.000309	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MED1—rheumatoid arthritis	7.09e-06	0.000308	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—rheumatoid arthritis	6.77e-06	0.000293	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO1—rheumatoid arthritis	6.73e-06	0.000292	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	6.72e-06	0.000291	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.62e-06	0.000287	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	6.6e-06	0.000286	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	6.6e-06	0.000286	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRKCQ—rheumatoid arthritis	6.58e-06	0.000285	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	6.5e-06	0.000282	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT1—rheumatoid arthritis	6.46e-06	0.00028	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	6.28e-06	0.000272	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAT—rheumatoid arthritis	6.1e-06	0.000265	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BGN—rheumatoid arthritis	5.94e-06	0.000258	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.91e-06	0.000256	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	5.9e-06	0.000256	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	5.74e-06	0.000249	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GC—rheumatoid arthritis	5.74e-06	0.000249	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	5.47e-06	0.000237	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	5.47e-06	0.000237	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.38e-06	0.000234	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	5.34e-06	0.000231	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	5.09e-06	0.000221	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CCR5—rheumatoid arthritis	4.94e-06	0.000214	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAT—rheumatoid arthritis	4.84e-06	0.00021	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—rheumatoid arthritis	4.83e-06	0.000209	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HLA-A—rheumatoid arthritis	4.81e-06	0.000209	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.81e-06	0.000208	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.71e-06	0.000204	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MED1—rheumatoid arthritis	4.68e-06	0.000203	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	4.46e-06	0.000193	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.38e-06	0.00019	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.35e-06	0.000189	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.35e-06	0.000189	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6ST—rheumatoid arthritis	4.22e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—rheumatoid arthritis	4.19e-06	0.000182	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—POMC—rheumatoid arthritis	4.07e-06	0.000177	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD80—rheumatoid arthritis	4.06e-06	0.000176	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	4.04e-06	0.000175	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAT—rheumatoid arthritis	3.94e-06	0.000171	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BGN—rheumatoid arthritis	3.92e-06	0.00017	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.83e-06	0.000166	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6R—rheumatoid arthritis	3.77e-06	0.000163	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—rheumatoid arthritis	3.71e-06	0.000161	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.6e-06	0.000156	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—rheumatoid arthritis	3.55e-06	0.000154	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TYK2—rheumatoid arthritis	3.43e-06	0.000149	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—rheumatoid arthritis	3.37e-06	0.000146	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	3.29e-06	0.000143	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	3.25e-06	0.000141	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—POMC—rheumatoid arthritis	3.23e-06	0.00014	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAT—rheumatoid arthritis	3.21e-06	0.000139	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—rheumatoid arthritis	3.1e-06	0.000135	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—rheumatoid arthritis	2.95e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.94e-06	0.000127	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—rheumatoid arthritis	2.82e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.68e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—POMC—rheumatoid arthritis	2.63e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—rheumatoid arthritis	2.4e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	2.29e-06	9.95e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—rheumatoid arthritis	2.23e-06	9.65e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—POMC—rheumatoid arthritis	2.14e-06	9.28e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.11e-06	9.17e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	2.1e-06	9.1e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.95e-06	8.46e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.87e-06	8.1e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.77e-06	7.66e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.71e-06	7.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—rheumatoid arthritis	1.68e-06	7.27e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.41e-06	6.12e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.29e-06	5.58e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.23e-06	5.34e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.13e-06	4.88e-05	CbGpPWpGaD
